Osaic Holdings
RKDA icon

Osaic Holdings’s Arcadia Biosciences RKDA Stock Holding History

Osaic Holdings’s Portfolio RKDA Stock Details RKDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-75
Closed -$148 – 8028
2025
Q4 		$148 Hold
75
– – ﹤0.01% 7614
2025
Q3 		$260 Hold
75
– – ﹤0.01% 7664
2025
Q2 		$323 Buy
+75
New +$296 ﹤0.01% 7437
2025
Q1 		– Sell
-75
Closed -$444 – 7668
2024
Q4 		$444 Hold
75
– – ﹤0.01% 7046
2024
Q3 		$205 Sell
75
-13
-15% -$37 ﹤0.01% 7169
2024
Q2 		$276 Buy
+88
New +$223 ﹤0.01% 7119
2021
Q4 		– Sell
-25
Closed -$2K – 7535
2021
Q3 		$2K Hold
25
– – ﹤0.01% 6882
2021
Q2 		$3K Sell
25
-133
-84% -$14.5K ﹤0.01% 6622
2021
Q1 		$17K Hold
158
– – ﹤0.01% 5592
2020
Q4 		$16K Buy
+158
New +$19.3K ﹤0.01% 5295
2020
Q3 		– Hold
0
– – – 6376

Other funds holding RKDA

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Osaic Holdings's RKDA Position: Q1 2026 in Review

Osaic Holdings sold out of Arcadia Biosciences (RKDA) in Q1 2026, closing a stake of 75 shares — an estimated $148 sold.

Osaic Holdings first reported a position in RKDA in Q4 2020 and held it in 10 quarters. The position peaked at $17K in Q1 2021. 16 funds tracked by Wall St. Rank hold RKDA as of Q1 2026.

  • Osaic Holdings reported no remaining Arcadia Biosciences position as of Q1 2026 after selling out during the quarter.
  • Osaic Holdings sold 75 Arcadia Biosciences shares in Q1 2026, an estimated $148.
  • Osaic Holdings first reported a position in Arcadia Biosciences in Q4 2020 and held it in 10 quarters.
  • Osaic Holdings's Arcadia Biosciences position peaked at $17K in Q1 2021.
  • 16 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.